Corbus Pharmaceuticals Holdings Inc’s recent filing unveils that its 10% Owner Cormorant Asset Management, LP acquired Company’s shares for reported $7.0 million on Sep 20 ’24. In the deal valued at $20.01 per share,350,000 shares were bought. As a result of this transaction, Cormorant Asset Management, LP now holds 2,375,000 shares worth roughly $28.31 million.
Then, CATLIN AVERY W bought 888 shares, generating $50,109 in total proceeds.
Before that, Moran Sean F. sold 9,355 shares. Corbus Pharmaceuticals Holdings Inc shares valued at $466,569 were divested by the Chief Financial Officer at a price of $49.87 per share. As a result of the transaction, Moran Sean F. now holds 48,605 shares, worth roughly $0.58 million.
Piper Sandler initiated its Corbus Pharmaceuticals Holdings Inc [CRBP] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. B. Riley Securities started covering the stock on June 26, 2024. It rated CRBP as “a Buy”.
Price Performance Review of CRBP
On Friday, Corbus Pharmaceuticals Holdings Inc [NASDAQ:CRBP] saw its stock fall -9.15% to $11.92. Over the last five days, the stock has gained 1.10%. Corbus Pharmaceuticals Holdings Inc shares have risen nearly 1.02% since the year began. Nevertheless, the stocks have risen 93.82% over the past one year. While a 52-week high of $61.90 was reached on 01/16/25, a 52-week low of $5.87 was recorded on 01/13/25. SMA at 50 days reached $15.14, while 200 days put it at $35.29.
Levels Of Support And Resistance For CRBP Stock
The 24-hour chart illustrates a support level at 11.45, which if violated will result in even more drops to 10.97. On the upside, there is a resistance level at 12.80. A further resistance level may holdings at 13.67. The Relative Strength Index (RSI) on the 14-day chart is 39.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.22, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.21%. Stochastics %K at 62.79% indicates the stock is a holding.
How much short interest is there in Corbus Pharmaceuticals Holdings Inc?
A steep rise in short interest was recorded in Corbus Pharmaceuticals Holdings Inc stocks on 2024-12-31, dropping by 94747.0 shares to a total of 2.41 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 2.51 million shares. There was a decline of -3.93%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 03, 2024 when Oppenheimer resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $80.
